# EDEN.PA Earnings Framework - FY2025 Results
**Fecha earnings:** 24 Febrero 2026
**Preparado:** 05 Febrero 2026 (actualizado)
**Framework:** v4.0

---

## 1. POSICION ACTUAL (actualizado 05-Feb-2026)

| Metrica | Valor |
|---------|-------|
| Shares | 22 |
| Avg Cost | EUR 20.87 |
| Current Price | EUR 17.73 |
| Position % | ~4% |
| Unrealized P&L | -15% |
| Quality Score | 62 (Tier B) |
| Fair Value | EUR 51.5 (base), EUR 33.5 (bear) |
| MoS actual | 65% (vs base FV) |
| Precio vs 52w low | +5% (low: 16.96) |

---

## 2. CONSENSO DE MERCADO

**FY2025 Net Income Consensus:** ~EUR 220m
**Target Price Consensus:** EUR 25.35

**Guidance Management:**
- FY2025: Expected in-line with consensus
- FY2026: "Rebasing year" con 2-4% growth (regulatory changes + portfolio optimization)
- FY2027-2028: Target 8-12% EBITDA like-for-like growth

**Factores clave:**
- Regulatory changes impactando employee benefits
- Portfolio optimization en curso
- Face value increases en benefits programs potencialmente positivos

---

## 3. ESCENARIOS DE EARNINGS

### BULL (probabilidad 20%)
**Net income > EUR 225m, 2026 outlook better than expected**

Que buscar:
- Net income >= EUR 225m (beat)
- FY2026 guidance revisado up (>4% growth)
- Positive surprise en regulatory impact mitigation
- Share buyback announcement
- Commentary positivo sobre pricing power

**Implicacion:** Tesis fortalecida significativamente. HOLD con conviccion reforzada.

### BASE (probabilidad 55%)
**Net income EUR 215-225m, 2026 guidance confirmado (2-4%)**

Que buscar:
- Net income EUR 215-225m (within consensus)
- FY2026 "rebasing year" confirmado (2-4%)
- FY2027-2028 target 8-12% reiterado
- Dividend estable (~EUR 1.10/share)
- Ejecucion de portfolio optimization en track

**Implicacion:** Tesis intacta. 2026 ya esta descontado. El valor esta en 2027+.

### BEAR (probabilidad 25%)
**Net income < EUR 215m o guidance 2026 peor de esperado**

Que buscar:
- Net income < EUR 215m (miss)
- FY2026 guidance <2% o guidance cut
- Regulatory headwinds peor de esperado
- Commentary negativo sobre competitive landscape
- Dividend cut o freeze multi-ano

**Implicacion:** Re-evaluar sizing. EDEN.PA ya esta -15% desde compra. Considerar si el bear case esta fully priced.

---

## 4. KILL CONDITIONS (monitorear en earnings call)

| Kill Condition | Status Pre-Earnings | Threshold |
|----------------|---------------------|-----------|
| ROIC deterioro | 25%+ | ROIC < 15% sustained |
| Revenue decline | Growth positive | Decline >5% 2Q consecutivos |
| Dividend cut | EUR 1.10/share | Cut >20% |
| Regulatory existential threat | Known headwind | New major regulation anunciada |
| Debt spike | Manageable | Net debt > 3x EBITDA |

---

## 5. DECISION TREE PRE-COMMITTED

```
EARNINGS RELEASE
|
+-> Net income >= EUR 225m + guidance up?
|   --> BULL: HOLD con conviccion reforzada
|
+-> Net income EUR 215-225m + 2026 guidance in-line (2-4%)?
|   --> BASE: HOLD (tesis intacta, 2026 rebasing priced in)
|
+-> Net income < EUR 215m?
|   |
|   +-> 2026 guidance mantenido (2-4%)?
|   |   --> HOLD (miss one-time, guidance intact)
|   |
|   +-> 2026 guidance cut (<2%)?
|       |
|       +-> 2027-2028 target 8-12% mantenido?
|       |   --> HOLD (delay, not cancellation)
|       |
|       +-> 2027-2028 target cut?
|           --> RE-EVALUAR: Considerar TRIM 50%
|
+-> KILL CONDITION TRIGGERED?
    --> SELL (exit completo)
```

---

## 6. CONTEXTO ESPECIAL: "REBASING YEAR" YA DESCONTADO

El mercado YA sabe que 2026 sera un ano de transicion. Precio actual EUR 17.73 vs target consensus EUR 25.35 implica:
- El mercado esta pricing in el 2026 debil
- El valor para nosotros esta en 2027-2028 recovery
- Un guidance "in-line" con 2-4% para 2026 NO deberia ser negativo

**Implicacion:** El bar para BEAR scenario es mas bajo. Solo un guidance PEOR que 2-4% seria verdaderamente negativo.

---

## 7. TIMING DE REACCION

| Escenario | Accion | Timing |
|-----------|--------|--------|
| BULL | Evaluar ADD | Wait 48h para confirmar |
| BASE | HOLD | No action needed |
| BEAR guidance intact | HOLD | Monitor closely |
| BEAR guidance cut | RE-EVAL | Sesion post-earnings |
| KILL | SELL | Inmediato |

---

## 8. CONTEXTO FRAMEWORK v4.0

**Precedente relevante (decisions_log.yaml):**
- Similar a TEP.PA: Tier C/B, underwater, earnings ahead
- HOLD fue decision cuando tesis intacta y kill conditions no triggered

**Principios aplicables:**
- P6: Vender requiere argumento - estar -15% NO es argumento
- P5: QS 62 (Tier B) merece paciencia
- P1: Sizing 4% es coherente con conviccion media-alta para Tier B

**Razonamiento pre-comprometido:**
EDEN.PA esta en un ciclo de "rebasing" conocido. El mercado ya priced in el 2026 debil. Nuestro FV base de EUR 51.5 asume recovery en 2027+. Un earnings que confirme el plan (incluso si debil en 2026) valida la tesis. Solo un deterioro del outlook 2027+ justificaria re-evaluacion.

---

## 9. POST-EARNINGS CHECKLIST

```
[ ] Net income vs EUR 220m consensus?
[ ] FY2026 guidance? (esperamos 2-4%)
[ ] FY2027-2028 target 8-12% reiterado?
[ ] Dividend announcement? (esperamos EUR 1.10)
[ ] Commentary sobre regulatory impact?
[ ] Portfolio optimization progress?
[ ] Kill condition triggered?
[ ] Price target consensus post-earnings?
```

---

**Sources:**
- [Yahoo Finance EDEN.PA Analysis](https://finance.yahoo.com/quote/EDEN.PA/analysis/)
- [Quartr Edenred Investor Relations](https://quartr.com/companies/edenred-sa_12533)
- [MarketScreener EDEN Forecasts](https://www.marketscreener.com/quote/stock/EDENRED-SE-6365724/finances/)
- [Simply Wall St Edenred Forecast](https://simplywall.st/stocks/fr/diversified-financials/epa-eden/edenred-shares/future)
